Jeonjinbio Co., Ltd. (KOSDAQ: 110020)
South Korea
· Delayed Price · Currency is KRW 2,705.00
-35.00 (-1.28%)
Sep 11, 2024, 9:00 AM KST
Jeonjinbio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 19,142 | 15,681 | 7,794 | 3,214 | 3,867 | 3,949 | Upgrade
|
| Other Revenue | -0 | - | -0 | - | - | - | Upgrade
|
| Revenue | 19,142 | 15,681 | 7,794 | 3,214 | 3,867 | 3,949 | Upgrade
|
| Revenue Growth (YoY) | 75.73% | 101.18% | 142.48% | -16.87% | -2.09% | 185.24% | Upgrade
|
| Cost of Revenue | 13,033 | 10,861 | 5,836 | 1,898 | 1,698 | 1,903 | Upgrade
|
| Gross Profit | 6,108 | 4,820 | 1,958 | 1,316 | 2,168 | 2,046 | Upgrade
|
| Selling, General & Admin | 3,792 | 3,937 | 3,346 | 3,716 | 3,399 | 3,118 | Upgrade
|
| Research & Development | 429.58 | 447.75 | 421.95 | 363.84 | 344.95 | 464.74 | Upgrade
|
| Other Operating Expenses | 139.67 | 134.69 | 111.8 | 82.76 | 64.93 | 52.51 | Upgrade
|
| Operating Expenses | 5,737 | 6,065 | 5,094 | 4,346 | 4,037 | 4,004 | Upgrade
|
| Operating Income | 371.55 | -1,245 | -3,136 | -3,030 | -1,869 | -1,958 | Upgrade
|
| Interest Expense | -869.55 | -1,195 | -2,035 | -865.67 | -515.62 | -315.29 | Upgrade
|
| Interest & Investment Income | 91.78 | 115.08 | 158.71 | 44.12 | 22.51 | 62.92 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.78 | 2.71 | -25.17 | -8.62 | -11.57 | 9.19 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,087 | -3,564 | 1,832 | 1,755 | -742.15 | 738.69 | Upgrade
|
| EBT Excluding Unusual Items | 669.08 | -5,886 | -3,205 | -2,105 | -3,116 | -1,462 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -16.64 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -194.3 | 9.94 | - | -2.91 | -5.63 | - | Upgrade
|
| Asset Writedown | -675.83 | -636.91 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | 73.29 | 91.69 | - | -280.13 | - | Upgrade
|
| Pretax Income | -201.06 | -6,440 | -3,113 | -2,108 | -3,418 | -1,462 | Upgrade
|
| Net Income | -201.06 | -6,440 | -3,113 | -2,108 | -3,418 | -1,462 | Upgrade
|
| Net Income to Common | -201.06 | -6,440 | -3,113 | -2,108 | -3,418 | -1,462 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 7 | 7 | 6 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 7 | 7 | 6 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | 12.04% | 10.68% | 6.14% | 27.16% | 2.69% | 12.46% | Upgrade
|
| EPS (Basic) | -25.77 | -884.03 | -473.00 | -340.00 | -701.00 | -308.00 | Upgrade
|
| EPS (Diluted) | -25.77 | -884.03 | -473.00 | -340.00 | -701.00 | -308.00 | Upgrade
|
| Free Cash Flow | 649.53 | -960.95 | -5,705 | -4,232 | -8,109 | -2,000 | Upgrade
|
| Free Cash Flow Per Share | 83.24 | -131.92 | -866.77 | -682.57 | -1662.96 | -421.16 | Upgrade
|
| Gross Margin | 31.91% | 30.74% | 25.13% | 40.94% | 56.08% | 51.80% | Upgrade
|
| Operating Margin | 1.94% | -7.94% | -40.23% | -94.26% | -48.34% | -49.58% | Upgrade
|
| Profit Margin | -1.05% | -41.07% | -39.94% | -65.59% | -88.40% | -37.03% | Upgrade
|
| Free Cash Flow Margin | 3.39% | -6.13% | -73.19% | -131.67% | -209.71% | -50.64% | Upgrade
|
| EBITDA | 2,082 | 590.48 | -1,744 | -2,663 | -1,429 | -1,532 | Upgrade
|
| EBITDA Margin | 10.88% | 3.77% | -22.37% | -82.84% | -36.97% | -38.80% | Upgrade
|
| D&A For EBITDA | 1,710 | 1,835 | 1,392 | 367.09 | 439.62 | 425.64 | Upgrade
|
| EBIT | 371.55 | -1,245 | -3,136 | -3,030 | -1,869 | -1,958 | Upgrade
|
| EBIT Margin | 1.94% | -7.94% | -40.23% | -94.26% | -48.34% | -49.58% | Upgrade
|
| Advertising Expenses | - | 219.26 | 164.76 | 374.4 | 301.25 | 119.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.